NOVKAN — Novakand Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK5.40m
- -SEK10.67m
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing
Brief: Novakand Pharma Q4 Operating Loss At SEK 5 Mln
Brief: Novakand Pharma Applies For Nasdaq's Approval Of Continued Listing
Brief: Novakand Pharma Buys SVF Vaccines
Brief: Novakand Pharma Enters LOI With Svf Vaccines
Brief: Novakand Pharma Q3 Net Sales Amounted To Sek 0 Million
Brief: Novakand Pharma Board Evaluates Reverse Takeover And Fractalkine Divestment
Brief: Novakand Pharma CEO Peter Selin Resigns
Brief: Kancera Changes Name To Novakand Pharma AB
Brief: Kancera To Seek Stakeholders For Reverse Take Over
Brief: Kancera Q2 Operating Loss Narrows To SEK 6.3 Million
Brief: Kancera Terminates Letter Of Intent With Recardio
Brief: Who Grants Inns For Kancera's Candidate Drugs Kand567 And Kand145
Brief: Kancera Reports Positive Top-Line Results From Kandova Study
Brief: Kancera Gets Positive FDA Feedback On Clinical Development Program For Kand567
Brief: Kancera Q1 Operating Loss At SEK 13.1 Mln